Details for 2022166818
Up to date per 01.04.2026
Actions
Details for 2022166818
Granted/Registered
European Patent
17.08.2022 A
11.01.2023 B1
31.08.2010
US
37883110 P
A61K 48/00 20060101AFI20220628BHEP
Owner
GlaxoSmithKline Biologicals SARue de l'Institut 89 1330 RixensartBE
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
GEALL, Andrew Emeryville, CA 94662-8097US
VERMA, Ayush Emeryville, CA 94662-8097US
Information about Fees